The safety and effectiveness of new drugs (market withdrawal of drugs containing cyclamates)
United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.Añadir a mi colección
Formato
Añadir a mi colección
Formato
También te puede gustar

Cyclamate sweeteners
United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.
1970
AñadirReport of the Temporary Committee for the Review of Data on Carcinogenicity of Cyclamate
United States. National Cancer Institute. Temporary Committee for the Review of Data on Carcinogenicity of Cyclamate.
1976
AñadirCyclamates
United States. Congress. House. Committee on the Judiciary. Subcommittee No. 2.
1972
AñadirCyclamates
United States. Congress. Senate. Committee on the Judiciary. Ad Hoc Subcommittee on Cyclamates.
1972
Añadir